Assessment of a novel device-based diagnostic algorithm to monitor patient status in moderate-to-severe heart failure: Rationale and design of the CLEPSYDRA study

European Journal of Heart Failure

Volumn 12, Issue 12, 2010, Pages 1363-1371

  Auricchio, Angelo ^a   Brugada, Josep ^b   Ellenbogen, Kenneth A ^c   Gold, Michael R ^d   Leyva, Francisco ^e  

^a DIVISION OF CARDIOLOGY   (Switzerland)

^b UNIVERSITY OF BARCELONA   (Spain)

^c VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^e QUEEN ELIZABETH HOSPITAL   (United Kingdom)

Author keywords

Heart failure; Implantable; Monitoring; Ventilation activity

Indexed keywords

ACCELEROMETER; ALGORITHM; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; CLINICAL TRIAL; CONTROLLED STUDY; DEVICE; DIAGNOSTIC VALUE; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; HEART FAILURE; HUMAN; LUNG MINUTE VOLUME; MULTICENTER STUDY; OUTCOME ASSESSMENT; PATIENT MONITORING; PRIORITY JOURNAL; QRS COMPLEX; SENSITIVITY ANALYSIS;

ALGORITHMS; DOUBLE-BLIND METHOD; HEALTH STATUS; HEALTH STATUS INDICATORS; HEART FAILURE; HUMANS; MONITORING, PHYSIOLOGIC; POISSON DISTRIBUTION; PROGNOSIS; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; STATISTICS AS TOPIC; UNITED STATES;

EID: 78649642704     PISSN: 13889842     EISSN: 18790844     Source Type: Journal    
DOI: 10.1093/eurjhf/hfq170     Document Type: Article

References (17)

1. Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJ, Ponikowski P, Poole-Wilson PA, Strömberg A, Van Veldhuisen DJ, Atar D, Hoes AW, Keren A, Mebazaa A, Nieminen M, Priori SG, Swedberg K. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur J Heart Fail 2008;10:933-989.
2. Stewart S, Jenkins A, Buchan S, McGuire A, Capewell S, McMurray JJ. The current cost of heart failure to the National Health Service in the UK. Eur J Heart Fail 2002;4:361-371.
3. Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG, Jessup M, Konstam MA, Mancini DM, Michl K, Oates JA, Rahko PS, Silver MA, Stevenson LW, Yancy CW. 2009 focused update incorporated into the ACC/ AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation 2009;119:e391-e479.
4. Van Veldhuisen DJ, Maass AH, Priori SG, Stolt P, Van Gelder IC, Dickstein K, Swedberg K. Implementation of device therapy (cardiac resynchronization therapy and implantable cardioverter defibrillator) for patients with heart failure in Europe: changes from 2004 to 2008. Eur J Heart Fail 2009;11:1143-1151.
5. Merkely B, Roka A, Kutyifa V, Boersma L, Leenhardt A, Lubinski A, Oto A, Proclemer A, Brugada J, Vardas PE, Wolpert C. Tracing the European course of cardiac resynchronization therapy from 2006 to 2008. Europace 2010;12: 692-701.
6. Cleland JG, Swedberg K, Follath F, Komajda M, Cohen-Solal A, Aguilar JC, Dietz R, Gavazzi A, Hobbs R, Korewicki J, Madeira HC, Moiseyev VS, Preda I, Van Gilst WH, Widimsky J, Freemantle N, Eastaugh J, Mason J. Study Group on Diagnosis of the Working Group on Heart Failure of the European Society of Cardiology. The EuroHeart Failure survey programme-a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis. Eur Heart J 2003;24:442-463. (Pubitemid 36286187)
7. Krumholz HM, Parent EM, Tu N, Vaccarino V, Wang Y, Radford MJ, Hennen J. Readmission after hospitalization for congestive heart failure among Medicare beneficiaries. Arch Intern Med 1997;157:99-104.
8. Solomon SD, Dobson J, Pocock S, Skali H, McMurray JJ, Granger CB, Yusuf S, Swedberg K, Young JB, Michelson EL, Pfeffer MA, Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) Investigators. Influence of nonfatal hospitalization for heart failure on subsequent mortality in patients with chronic heart failure. Circulation 2007;116:1482-1487.
9. Braunschweig F, Ford I, Conraads V, Cowie MR, Jondeau G, Kautzner J, Lunati M, Munoz Aguilera R, Man Yu C, Marijianowski M, Borggrefe M, Van Veldhuisen DJ, DOT-HF Steering Committee and Investigators. Can monitoring of intrathoracic impedance reduce morbidity and mortality in patients with chronic heart failure? Rationale and design of the Diagnostic Outcome Trial in Heart Failure (DOT-HF). Eur J Heart Fail 2008;10:907-916.
10. Page E, Cazeau S, Ritter P, Galley D, Casset C. Physiological approach to monitor patients in congestive heart failure: application of a new implantable device-based system to monitor daily life activity and ventilation. Europace 2007;9: 687-693.
11. Bourge RC, Abraham WT, Adamson PB, Aaron MF, Aranda JM Jr, Magalski A, Zile MR, Smith AL, Smart FW, O'Shaughnessy MA, Jessup ML, Sparks B, Naftel DL, Stevenson LW, COMPASS-HF Study Group. Randomized controlled trial of an implantable continuous hemodynamic monitor in patients with adVanced heart failure: the COMPASS-HF study. J Am Coll Cardiol 2008;51: 1073-1079.
12. Simon R, Ni Q, Willems R, Hartley JW, Daum DR, Lang D, Ward K, Gill J. Comparison of impedance minute ventilation and direct measured minute ventilation in a rate adaptive pacemaker. Pacing Clin Electrophysiol 2003;26: 2127-2133.
13. Arena R, Myers J, Guazzi M. The clinical and research applications of aerobic capacity and ventilatory efficiency in heart failure: an evidence-based review. Heart Fail Rev 2008;13:245-269.
14. Arena R, Myers J, Hsu L, Peberdy MA, Pinkstaff S, Bensimhon D, Chase P, Vicenzi M, Guazzi M. The minute ventilation/carbon dioxide production slope is prognostically superior to the oxygen uptake efficiency slope. J Card Fail 2007;13:462-469.
15. Cleland JGF, Daubert J-C, Erdmann E, Freemantle N, Gras D, Kappenberger L, Tavazzi L. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005;352:1539-1549. (Pubitemid 40517094)
16. Yu CM, Wang L, Chau E, Chan RH, Kong SL, Tang MO, Christensen J, Stadler RW, Lau CP. Intrathoracic impedance monitoring in patients with heart failure: correlation with fluid status and feasibility of early warning preceding hospitalization. Circulation 2005;112:841-848.
17. Cowie MR, Conraads V, Tavazzi L, Yu CM, SENSE-HF Investigators. Rationale and design of a prospective trial to assess the sensitivity and positive predictive value of implantable intrathoracic impedance monitoring in the prediction of heart failure hospitalizations: the SENSE-HF study. J Card Fail 2009;15: 394-400.